Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00111670 · ClinicalTrials.gov registry record · Phase 2

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

A Phase 2 study of Diabetes Mellitus, Type 2, sponsored by Hoffmann-La Roche.

Completed
Registry status
Phase 2
Development phase
291
Enrollment target
20
Study locations

NCT00111670 is a Phase 2 study of Diabetes Mellitus, Type 2 that has completed, run by Hoffmann-La Roche. The registered enrollment target is 291 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00111670, a Phase 2 study of Diabetes Mellitus, Type 2, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
Phase 2
Development phase
291 participants
Enrollment target
20
Study locations

Study Summary

This study will assess the efficacy, safety and tolerability of DPP-IV Inhibitor compared to placebo in patients with type 2 diabetes. The anticipated time on study treatment is \< 3 months and the target sample size is 100-500 individuals.

Conditions Studied

Diabetes Mellitus, Type 2

Interventions

  • DRUG Placebo
  • DRUG DPP-IV Inhibitor

Study Locations (20)

Florida

  • - Clearwater
  • - Hialeah
  • - Pembroke Pines

Texas

  • - Dallas
  • - Midland
  • - San Antonio

Maryland

  • - Elkton
  • - Oxon Hill

Virginia

  • - Richmond
  • - Virginia Beach

Other

  • - Rousse
  • - Sofia

California

  • - Salinas

Georgia

  • - Blue Ridge

Illinois

  • - Aurora

Trial Details

FieldValue
Enrollment Target 291 participants
Start Date 2005-06
Est. Completion 2006-07
Phase Phase 2

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00111670

The ClinicalTrials.gov registry entry for NCT00111670 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 291 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (94% lower). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00111670 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Texas, Maryland.

Frequently Asked Questions

What is clinical trial NCT00111670 about?

NCT00111670 is a clinical study titled "A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes". This study will assess the efficacy, safety and tolerability of DPP-IV Inhibitor compared to placebo in patients with type 2 diabetes. The anticipated time on study treatment is \< 3 months and the target sample size is 100-500 individuals.

What is the current status of trial NCT00111670?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 291 participants. The study started on 2005-06. Estimated completion is 2006-07.

What conditions does trial NCT00111670 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00111670?

The interventions under investigation include: Placebo (DRUG), DPP-IV Inhibitor (DRUG).

Who is sponsoring clinical trial NCT00111670?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00111670 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.